Today we have reached 450 patients recruited in the PROMISE study, the validation of a patient-reported outcome scale in acute pancreatitis. Our aim is to have a tool to be an easy outcome variable to test new treatments in acute pancreatitis. Currently we have centers from Greece, Hungary, Mexico, Poland, Portugal, Romania, Russia, South Korea, Spain, Ukraine and USA actively recruiting patients. We expect to close the study in less than 6 months. We have also presented the first abstract from the PROMISE database in the last EPC meeting (Berlin June 2018).
Thanks for your commitment!